Literature DB >> 17161851

Survey of polymorphic sequence variation in the immediate 5' region of human DNA repair genes.

Harvey Mohrenweiser1.   

Abstract

Systematic screens have revealed extensive DNA sequence variation existing in the human population. Studies of the role of polymorphic genetic variants in explaining the association of family history with risk of common disease have generally focused on variants predicted to disrupt protein structure and activity. Recent studies have identified genetic variation in the level of expression of many genes, variation that is potentially biologically relevant in explaining individual variation in disease risk. In a survey of data available for 108 DNA repair genes that have been systematically screened for sequence variation, an average of 3.3 SNPs per gene were found to exist at a variant allele frequency of at least 0.02 in the region 2kb upstream from the 5'-untranslated region. One-third of the genes harbored a SNP with an allele frequency of at least 0.02 within a predicted promotor element. These variants are distributed among promoter elements that average 20 elements per gene. The frequency of polymorphic SNPs in CpG islands was 0.8 per gene, while the frequency of SNPs in the 5'-UTR was 0.7 per gene. The recognition of extensive genetic variation with potential to impact levels of gene expression, and thereby exacerbate the impact of amino acid substitution variants on the activity of proteins, increases the complexity of analyses required to explain the molecular genetic basis for the familial contribution to the sporadic incidence of common disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17161851     DOI: 10.1016/j.mrfmmm.2006.11.008

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  6 in total

1.  XPA A23G polymorphism and lung cancer risk: a meta-analysis.

Authors:  Ji-Hong Zou; Li An; Shi Chen; Li-Qun Ren
Journal:  Mol Biol Rep       Date:  2011-05-25       Impact factor: 2.316

2.  A 5'-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2A.

Authors:  Francesca Colombo; Felicia S Falvella; Antonella Galvan; Elisa Frullanti; Hideo Kunitoh; Toshikazu Ushijima; Tommaso A Dragani
Journal:  Mol Cancer       Date:  2011-07-07       Impact factor: 27.401

3.  Functional Analysis of SNPs in the ERCC5 Promoter in Advanced Colorectal Cancer Patients Treated With Oxaliplatin-Based Chemotherapy.

Authors:  Jianfang Chen; Xi Luo; Ganfeng Xie; Keli Chen; Heng Jiang; Feng Pan; Jianjun Li; Zhihua Ruan; Xueli Pang; Houjie Liang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

4.  Polymorphisms in the ERCC5 gene and risk of esophageal squamous cell carcinoma (ESCC) in Eastern Chinese populations.

Authors:  Mei-Ling Zhu; Ting-Yan Shi; Hai-Chuan Hu; Jing He; Mengyun Wang; Li Jin; Ya-Jun Yang; Jiu-Cun Wang; Meng-Hong Sun; Huan Chen; Kuai-Le Zhao; Zhen Zhang; Hai-Quan Chen; Jia-Qing Xiang; Qing-Yi Wei
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

5.  Association between single nucleotide polymorphisms in ERCC4 and risk of squamous cell carcinoma of the head and neck.

Authors:  Hongping Yu; Zhensheng Liu; Yu-Jing Huang; Ming Yin; Li-E Wang; Qingyi Wei
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

6.  XPG rs2296147 T>C polymorphism predicted clinical outcome in colorectal cancer.

Authors:  Fang Wang; Shao-Dan Zhang; Hong-Mei Xu; Jin-Hong Zhu; Rui-Xi Hua; Wen-Qiong Xue; Xi-Zhao Li; Tong-Min Wang; Jing He; Wei-Hua Jia
Journal:  Oncotarget       Date:  2016-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.